1 / 25

Antimicrobial Susceptibility Testing (AST)

Antimicrobial Susceptibility Testing (AST). MLAB 2434 – Microbiology Keri Brophy-Martinez. Reasons and Indications for Antimicrobial Susceptibility Testing (AST). Goal Offer guidance to physician in selecting effective antibacterial therapy for a pathogen in a specific body site

azize
Télécharger la présentation

Antimicrobial Susceptibility Testing (AST)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Antimicrobial Susceptibility Testing (AST) MLAB 2434 – Microbiology Keri Brophy-Martinez

  2. Reasons and Indications for Antimicrobial Susceptibility Testing (AST) • Goal • Offer guidance to physician in selecting effective antibacterial therapy for a pathogen in a specific body site • Performed on bacteria isolated from clinical specimens if the bacteria’s susceptibility to particular antimicrobial agents is uncertain • Susceptibilities NOT performed on bacteria that are predictably susceptible to antimicrobials • Ex. Group A Strep

  3. Factors to Consider When Determining Whether Testing is Warranted • Body site of infection • Susceptibility not performed on bacteria isolated from body site where they are normal flora • Ex. Susceptibility for E. coli is NOT performed when isolated from stool, but IS performed when isolated from blood

  4. Factors to Consider When Determining Whether Testing is Warranted (cont’d) • Presence of other bacteria and quality of specimen • Ex. Two or more organisms grown in a urine specimen • Host status • Immunocompromised patients • Allergies to usual antimicrobials

  5. Selecting Antimicrobial Agents for Testing and Reporting • Clinical & Laboratory Standards Institute (CLSI) • Develop standards, methods, QC parameters, and interpretive criteria for sensitivity testing • If necessary, can alter the breakpoints of the SIR ( susceptible, intermediate, resistant) based on emerging resistance

  6. Selecting Antimicrobial Agents for Testing and Reporting (cont’d) • There are approximately 50 antibacterial agents • Follow CLSI recommendations • Each laboratory should have a battery of antibiotics ordinarily used for testing • Drug formulary decided by medical staff, pharmacists, and medical technologists

  7. Selection of Test Batteries • Generally, labs choose 10-15 antibiotics to test susceptibility for GP organisms and another 10-15 for GN organisms • Too many choices can confuse physicians and be too expensive • Primary objective • Use the least toxic, most cost-effective, and most clinically appropriate agents • Refrain from more costly, broader-spectrum agents

  8. Example of Drug Formulary

  9. Example of Drug Formulary

  10. Definitions • Minimum inhibitory concentration(MIC) • Lowest concentration of an antimicrobial agent that visibly inhibits the growth of the organism. • Minimum bactericidal concentration (MBC) • Lowest concentration of the antimicrobial agent that results in the death of the organism.

  11. Definitions (cont’d) • Susceptible ”S” • Interpretive category that indicates an organism is inhibited by the recommended dose, at the infection site, of an antimicrobial agent • Intermediate “I” • Interpretive category that represents an organism that may require a higher dose of antibiotic for a longer period of time to be inhibited • Resistant “R” • Interpretive category that indicates an organism is not inhibited by the recommended dose, at the infection site, of an antimicrobial agent.

  12. Methods of Performing AST • Agar dilution method • Broth macrodilution / Tube dilution • Broth microdilution • Disk diffusion method • Gradient diffusion method (E-Test)

  13. Standardization of Antimicrobial Susceptibility Testing • Inoculum Preparation • Use 4-5 colonies NOT just 1 colony • Inoculum Standardization • using 0.5 McFarland standard

  14. Methods of Performing AST • Agar Dilution • Dilutions of antimicrobial agent added to agar • Growth on agar indicates MIC • Broth macrodilution/Tube Dilution Tests • Two-fold serial dilution series, each with 1-2 mL of antimicrobial • Too expensive and time consuming • Microdilution Tests • plastic trays with dilutions of antimicrobials

  15. Disk Diffusion/ Kirby- Bauer • Procedure • Use a well-isolated, 18-24 hour old organism • Transfer organism to a broth • Either tryptic soy/sterile saline • Ensure a turbidity of 0.5 McFarland • Inoculate MH agar by swabbing in three different directions “Lawn of growth” • Place filter paper disks impregnated with anitmicrobial agents on the agar • Invert and incubate for 16-18 hours at35 oC in non-CO2

  16. Disk Diffusion/ Kirby-Bauer (cont’d) • During incubation, drug diffuses into agar • Depending on the organism and drug, areas of no growth form a zone of inhibition • Zones are measured to determine whether the organism is susceptible, intermediate, or resistant to the drug

  17. E- test/ Gradient Diffusion Method • “MIC on a stick” • Plastic strips impregnated with antimicrobial on one side • MIC scale on the other side • Read MIC where zone of inhibition intersects E strip scale

  18. Automated Antimicrobial Susceptibility Test Methods • Detect growth in microvolumes of broth with various dilutions of antimicrobials • Detection via photometric, turbidimetric, or fluorometric methods • Types • BD Phoenix • Microscan Walkaway • TREK Sensititre • Vitek 1 and 2

  19. Automated Antimicrobial Susceptibility Test Methods • Advantages • Increased reproducibility • Decreased labor costs • Rapid results • Software • Detects multi-drug resistances • ESBLs • Correlates bacterial ID with sensitivity • Disadvantages • Cost

  20. Quality Control in Susceptibility Testing • Reflects types of patient isolates & range of susceptibility • Frequency of quality control depends on method, CLSI, or manufacturer • Reference strains of QC material • American Type Culture Collection(ATCC) • E. coli ATCC* 25922 • S. aureus ATCC* 25923

  21. The Superbugs • Organisms resistant to previously effective drugs • MRSA • methicillin-resistant Staphylococcus aureus • mecA gene codes for a PBP that does not bind beta-lactam antibiotics • Resistant to oxacillin • Vancomycin • VRE –Enterococcus species • VISA/VRSA- Staphylococcus aureus

  22. The Superbugs:The Beta-Lactamases • Gram negative rods that have genes on chromosomes that code for enzymes against certain antimicrobials • ESBLs-extended spectrum beta lactamase • Resistant to extended spectrum cephalosporins, penicillins, aztreonam • Examples: E. coli, Klebsiella • Carbapenemases (CRE) • Klebsiella pneumoniae- KPC- Class A • Class B (NDM, VIM, IMP)- metallo beta lactamases • Resistant to penicillins, cephalosporins, carbapenems, and aztreonam • Cephalosporinases • AmpC enzyme • inducible • “SPACE” organisms

  23. Controlling the Superbugs • Lab’s Role • Recognize and report isolates recovered from clinical specimens • Methods for identification include automated systems and screening agars

  24. Controlling the Superbugs • Role of Health Care Workers/Facilities • Hand hygiene with the use of alcohol-based hand rubs or soap and water after patient care • Contact precautions for patients identified as colonized or infected with a superbug • Healthcare personnel education about the methods of transmission, contact precautions, and proper use of hand hygiene • Minimization of invasive devices (catheters, etc.) • Proper administration of antimicrobial agents where therapy is selected for susceptible organisms for the proper duration

  25. References • http://www.biomerieux-diagnostics.com/servlet/srt/bio/clinical-diagnostics/dynPage?doc=CNL_CLN_PRD_G_PRD_CLN_22 • http://www.cdc.gov/std/gonorrhea/lab/diskdiff.htm • http://www.who.int/drugresistance/Antimicrobial_Detection/en/index.html • Kiser, K. M., Payne, W. C., & Taff, T. A. (2011). Clinical Laboratory Microbiology: A Practical Approach . Upper Saddle River, NJ: Pearson Education. • Mahon, C. R., Lehman, D. C., & Manuselis, G. (2011). Textbook of Diagnostic Microbiology (4th ed.). Maryland Heights, MO: Saunders. • Murray, P. R. (2013, May). Carbapenem-resistant Enterobacteriaceae: what has happened, and what is being done. MLO, 45(5), 26-30.

More Related